Rituximab in pediatric renal transplantation: a treatment for allograft rejection with B-cell infiltrates?

Am J Transplant. 2008 Dec;8(12):2489-90. doi: 10.1111/j.1600-6143.2008.02454.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / metabolism
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • Child
  • Child, Preschool
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / pathology*
  • Graft Rejection / prevention & control*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Kidney Transplantation / immunology*
  • Male
  • Randomized Controlled Trials as Topic
  • Rituximab
  • Transplantation, Homologous
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Immunologic Factors
  • Rituximab